Showing results (131-140 of 208) with videos related to
Sort By:
Pageof 21
The Journal of Trauma|October 1, 1985
Response of random skin flaps to rapid expansionM W Marks, J R Mackenzie, R E Burney, et al.Translational Oncology|December 23, 2011
Cell Internalization Studies of Gadofullerene-(ZME-018) Immunoconjugates into A375m Melanoma CellsChristopher Scott Berger, John W Marks, Robert D Bolskar, et al.Annals of Plastic Surgery|April 9, 2021
The Triangular Dart Flap: A Reconstructive Option for Soft Tissue DefectsThomas N Steele, Lauren E Blaha, Olivia P Madan, et al.Annals of Plastic Surgery|February 25, 2010
Outcomes analysis of a resident cosmetic clinic: safety and feasibility after 7 yearsJeremy W Pyle, Jeff O Angobaldo, Allyson K Bryant, et al.Vox Sanguinis|January 15, 2016
Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testingH Yang, S A Anderson, R Forshee, et al.Frontiers in Physiology|March 9, 2026
An evidence-based multi-factorial model to predict the oxygen cost of ventilation during ramp-incremental cycle ergometry exerciseBridgette G J O'Malley, Robert A Robergs, Karel Hrach, et al.Annals of Plastic Surgery|June 2, 2011
Outcome study of the surgical management of panniculitisJohn Zannis, Benjamin C Wood, Leah P Griffin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft modelsM G Rosenblum, L K Shawver, J W Marks, et al.Cancer Research|November 26, 2009
Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studiesYu Cao, James D Marks, John W Marks, et al.Oncogene|February 5, 2013
Design optimization and characterization of Her2/neu-targeted immunotoxins: comparative in vitro and in vivo efficacy studiesY Cao, J W Marks, Z Liu, et al.Pageof 21